An FDA advisory panel began a two-day meeting on Thursday to examine more than a half-dozen peptides, with Health Secretary Robert F. Kennedy Jr. supporting expanded access through compounding pharmacies. PBS NewsHour reports that career FDA scientists cite insufficient data for broader availability, while supporters including Joe Rogan and Gary Brecka back the review. The meeting follows Kennedy's pledge to reverse prior restrictions on these customized compounds.